[Clinical characteristics of primary and secondary aldosteronism].
Nishikawa
Tetsuo
T
Division of Endocrinology and Metabolism, Department of Medicine, Yokohama Rosai Hospital.
Saito
Jun
J
D000236:Adenoma / Q000150:complications / Q000378:metabolism; D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000378:metabolism; D000450:Aldosterone / Q000096:biosynthesis; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004487:Edema / Q000150:complications; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D012083:Renin / Q000097:blood; D012084:Renin-Angiotensin System / Q000502:physiology; D013148:Spironolactone / Q000627:therapeutic use
D013148:Spironolactone; D000450:Aldosterone; D005665:Furosemide; D012083:Renin